Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

Immunotoxin therapy of malignancy

M L Grossbard, L M Nadler

Important Advances in Oncology

|January 1, 1992

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014

Same author

The relationship of chronic lymphocytic leukemia to normal activated B cells.

Leukemia & lymphoma·2010

Same author

Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.

Leukemia·2008

Same author

131I tositumomab: a viewpoint by Michael L. Grossbard.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007

Same author

Rapid, reliable and inexpensive quality assessment of biotinylated cRNA.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2006

Same author

Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.

Leukemia & lymphoma·2005

Related Experiment Videos

Immunotoxin therapy of malignancy

Related Concept Videos

Related Articles

Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.

The relationship of chronic lymphocytic leukemia to normal activated B cells.

Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.

131I tositumomab: a viewpoint by Michael L. Grossbard.

Rapid, reliable and inexpensive quality assessment of biotinylated cRNA.

Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.